Long‐term survival of a patient with lung cancer treated with pembrolizumab after recurrent cardiac tamponade
oleh: Tsuyoshi Uchida, Hirochika Matsubara, Mamoru Muto, Harunobu Sasanuma, Saya Sugimura, Yuichiro Onuki, Hiroyuki Nakajima
| Format: | Article |
|---|---|
| Diterbitkan: | Wiley 2022-12-01 |
Deskripsi
Abstract A 69‐year‐old man with non‐small cell lung cancer presenting with pericardial effusion and rapid progression of dyspnea achieved long‐term disease stabilization after radiation therapy and immunotherapy. This case shows that pembrolizumab may improve prognosis in advanced lung cancer, even when complicated by cardiac tamponade.